# TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy

> **NCT02289079** · PHASE4 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 60 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** liposomal bupivacaine

## Key facts

- **NCT ID:** NCT02289079
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289079, "TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02289079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*